AzTrials
AzTrials

Phobic DisordersPACTE-qNCT02387047

Validity of a Self-administered Questionnaire to Screen Phobia of Falling in the Elderly

An observational study of Phobic Disorders, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to determine the validity of a self-questionnaire detecting seniors phobia of falling living at home. A prospective monocentric observational study compares in a blind way the presence of Diagnostic and Statistical Manual of Mental Disorders fourth edition (DSM-IV) criteria for specific… Read more about this study

Who is it for?
Ages 70 years and older
Conditions the study is for
Phobic Disorders
How many people
41 participants
Where
1 siteFrance
Study dates
Nov 2014to Oct 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Consecutive patients aged 70 years or more, consulting in geriatric day hospital, presenting walking difficulties and/or disturbance of the balance and/or at least one fall during the course of the last 5 years and/or a fear of falling, living in community

Who may be able to join

  • Aged 70 years and over
  • Presenting walking difficulties and/or disturbance of the balance and/or at least one fall during the course of the last 5 years and/or a fear of falling
  • Living in community
  • Non opposition of the patient to the collection of his personal data

Who cannot join

  • Depression
  • Cognitive disorders
  • Inability to communicate

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpital Bretonneau

    Paris, 75018

Other trials in France

About this study

Official title: Screening for Phobia of Falling in the Elderly: Validity and Feasibility of a Self-administered Questionnaire

The aim of this study is to determine the validity of a self-questionnaire detecting seniors phobia of falling living at home. A prospective monocentric observational study compares in a blind way the presence of Diagnostic and Statistical Manual of Mental Disorders fourth edition (DSM-IV) criteria for specific phobia, considered as the gold standard to the score obtained at the detecting questionnaire for ≥70 years old seniors suspected of phobia of falling and attending geriatric day hospital at the Bretonneau hospital (APHP, Paris).

Read the detailed description

Context : The phobia of falling strongly contributes to the frailty of the elderly, and plays a key role in falls occuring and their deleterious effect. It concerns a big part of seniors living at home, fell before or not, and frequently leads to a restriction of their mobility. When the phobia of falling occurs, the fear of falling down takes an excessive scope, it is associated with anxious reactions when seniors dread the risk, and leads them to avoid these situations reducing their mobility. This reduction of activities contributes to the premature decline of physical capacities, worsens social life, increases the falling and institutionalization risk. However, there is no specific tools for the detection of seniors falling phobia, enabling us to turn patients towards a therapeutic and diagnostical adapted care. A detecting self-questionnaire was thus designed by the research geriatric team after an analysis of the literature and half-directive interviews with a representative sample of the target population.

Objectives : The main objective of this study is to evaluate the validity of a self-questionnaire so as to detect falling phobic seniors living at home. The optimal threshold of the questionnaire score, obtained from a receiver operating characteristic curve (ROC curve), will let us evaluate its concordance compared to the gold standard, formed by DSM-IV criteria for specific phobia. The results of the questionnaire will be kept secret while the study occurs. The secondary objectives will be to control the feasibility of the self-questionnaire detecting phobia of falling, the validity of internal structure and external construction by the exploration of its correlation with other close psychological and physical health measures.

Design : A 1 year prospective monocentric observational study is led with seniors attending geriatric day hospital at the Bretonneau hospital (APHP, Paris). While the same day hospital, all eligible patients will have a current evaluation of cares adapted to their admission causes. These patients will fill out the self-questionnaire detecting phobia, designed by the research geriatric team. The final clinical diagnostic of phobia of falling will be disconfirmed or affirmed from DSM-IV-TR (TR stands for text revision) criteria. At the end of the day hospital, an adapted care to their pathologies will be suggested to all the patients, according to usual practice.

Medical subject headings
Phobic Disorders

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Concordance of the self-questionnaire score compared to the gold standard formed by DSM-IV criteria for specific phobia presence

    In a first time, the optimal threshold of the self-questionnaire score will be determined with a ROC curve. In a second time, this threshold will let us evaluate the score concordance compared to reference method.

    Measured: 1 day

Secondary outcomes (14)
  1. Percentage of filled out self-questionnaires

    Evaluation of construct validity of the self-questionnaire

    Measured: 1 day

  2. Item response rate

    Evaluation of construct validity of the self-questionnaire

    Measured: 1 day

  3. Help requirement to fill out the self-questionnaire

    Evaluation of construct validity of the self-questionnaire

    Measured: 1 day

  4. Time to complete the self-questionnaire

    Evaluation of construct validity of the self-questionnaire

    Measured: 1 day

  5. Patients' satisfaction with the self-questionnaire

    Evaluation of construct validity of the self-questionnaire

    Measured: 1 day

  6. Life-space mobility assessed by the Life-Space Assessment

    Measured: 1 day

  7. Comorbidity assessed by the Cumulative Illness Rating Scale for Geriatrics

    Measured: 1 day

  8. History of falls, number and gravity

    Measured: 1 day

  9. Frailty assessment according to phenotype definition of Fried

    Evaluation of construct validity of the self-questionnaire

    Measured: 1 day

  10. The Fear Questionnaire

    Measured: 1 day

  11. The Mobility Inventory for Agoraphobia

    Measured: 1 day

  12. Fear of falling assessed by the Falls Efficacy Scale-International

    Measured: 1 day

  13. Self-rated health assessed by the Minimum European Health Module

    Measured: 1 day

  14. The Timed Up and Go, performance-Oriented Mobility Assessment, 10-m walk test, the 30-s chair-stand test

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2015 (estimated)
  2. Study startNov 2014
  3. Primary completionOct 2015
  4. Study completionOct 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02387047
Sponsor's protocol ID
14SDE-PACTEQ
Acronym
PACTE-q
Status last verified
Oct 2015
First submitted
27 Jan 2015
Last updated
4 Nov 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Phobic Disorders, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Nov 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Concordance of the self-questionnaire score compared to the gold standard formed by DSM-IV criteria for specific phobia presence (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in